These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: New 1,2,4-oxadiazole derivatives: synthesis and adrenergic receptors binding studies.
    Author: Brizzi V, Brufani M, Filocamo L, Bruni G, Fiaschi AI.
    Journal: Farmaco; 1992 Jun; 47(6):953-66. PubMed ID: 1326978.
    Abstract:
    In order to obtain derivatives with simultaneous alpha- and beta-adrenergic blocking activity, compounds having the phenoxypropanolaminic structure of beta-adrenergic blockers have been synthesised, as well as 1,2,4-oxadiazole moiety, which could imitate the imidazolinic nucleus characteristic of drugs acting on alpha-adrenergic receptors. The synthesised compounds have been submitted to alpha and beta receptor binding assays. Some derivatives showed an alpha-adrenoceptor binding activity higher than labetalol and similar to prazosin, but with a poor beta-adrenoceptor binding activity.
    [Abstract] [Full Text] [Related] [New Search]